PURPOSE: The Department of Health and Senior Services has prepared a list of all drugs falling within the purview of controlled substances. PUBLISHER’S NOTE: The secretary of state has determined that publication of the entire text of the material that is incorporated by reference as a portion of this rule would be unduly cumbersome or expensive. This material as incorporated by reference in this rule shall be maintained by the agency at its headquarters and shall be made available to the public for inspection and copying at no more than the actual cost of reproduction. This note applies only to the reference material. The entire text of the rule is printed here. (1) Schedules of Controlled Substances.

1. (A) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Drug Enforcement Administration (DEA) Controlled Substances Code Number set forth opposite it.

   1. 1. Opiates. Unless specifically excepted or unless listed in

another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

1. A. Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)- 4-piperidinyl)-N- phenylacetamide)
2. B. Acetylmethadol
3. C. Acetyl fentanyl (N-(1- phenethylpiperidin-4-yl)- N-phenylacetamide)
4. D. N-(1-phenethylpiperidin- 4-yl)-N-phenylacrylamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other names: acryl fentanyl, acryloylfentanyl)
5. E. AH-7921(3,4-dichloro- N-[(1-dimethylamino) cyclohexylmethyl] benzamide)
6. F. Allylprodine
7. G. Alphacetylmethadol (except levoalphacetylmethadol also known as levo-alphaacetylmethadol levothadyl acetate or LAAM)
8. H. Alphameprodine
9. I. Alphamethadol
10. J. alpha′-Methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin- 4-yl)-N-phenylbutanamide)
11. K. Alpha-methylfentanyl (N-1-(alphamethyl-betaphenyl) ethyl-4-piperidyl) propionanilide; 1-(1-methyl- 2-phenylethyl)-4 ((N- propanilido) piperidine)

1. L. Alpha-methylthiofentanyl (N-(1-methyl-2-(2-thienyl) ethyl-4-piperidinyl)-N- phenylpropanamide)
2. M. Benzethidine
3. N. Betacetylmethadol
4. O. Beta-hydroxyfentanyl (N-(1-(2-hydroxy-2- phenethyl)-4-piperidinyl)- N-phenylpropanamide)
5. P. Beta-hydroxy-3- methylfentanyl (other name: N-(1-(2-hydroxy-2-phenethyl)- 3-methyl-4-piperidinyl)-N- phenylpropanamide)
6. Q. N-[1-[2-hydroxy-2-(thiophen- 2-yl) ethyl]piperidin-4-yl]- N-phenylpropionamide (other names: beta-hydroxythiofentanyl)
7. R. Betameprodine
8. S. Betamethadol
9. T. beta-Methyl fentanyl (N-phenyl-N-(1-(2- phenylpropyl)piperidin-4-yl) propionamide (Other name: β-methyl fentanyl)
10. U. beta'-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)- N,3-diphenylpropanamide (other names: β'-phenyl fentanyl; 3-phenylpropanoyl Fentanyl)
11. V. Betaprodine
12. W. Brorphine (1-(1-(1-(4-bromophenyl) ethyl)piperidin-4-yl)-1,3-dihydro-2H- benzo[d]imidazol-2-one)
13. X. Butyryl fentanyl (N- (1-phenethylpiperidin-4-yl)- N-phenylbutyramide)
14. Y. Clonitazene
15. Z. Crotonyl fentanyl ((E)-N-(1- phenethylpiperidin-4-yl)-N- phenylbut-2-enamide) AA. N-(1-phenethylpiperidin- 4-yl)-N- Phenylcyclopentanecarboxamide (other name: cyclopentyl fentanyl) BB. Cyclopropyl fentanyl (N-(1- phenethylpiperidin-4-yl)-N- phenylcyclopropanecarboxamide)
16. CC. Dextromoramide
17. DD. Diampromide EE. Diethylthiambutene FF. Difenoxin GG. Dimenoxadol HH. Dimepheptanol
18. II. 2′,5′-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl) piperidin-4-yl)-N- phenylpropionamide) JJ. Dimethylthiambutene KK. Dioxaphetyl butyrate
19. LL. Dipipanone
20. MM. Ethylmethylthiambutene NN. 2-(2-(4-ethoxybenzyl)-1H- benzimidazol-1-yl)-N, N- diethylethan-1-amine (other names: etodesnitazene; etazene) OO. Etonitazene PP. Etoxeridine QQ. Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl) (phenyl)carbamate) RR. N-(4-fluorophenyl)-N- (1-phenethylpiperidin-4- yl)isobutyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other names: 4-fluoroisobutyryl fentanyl, parafluoroisobutyryl fentanyl) SS. 2'-Fluoro orthofluorofentanyl (N-(1-(2- fluorophenethyl) piperidin- 4-yl)-N-(2-fluorophenyl) propionamide (other names: 2'-fluoro 2-fluorofentanyl) TT. N-(1-phenethylpiperidin- 4-yl)-N-phenylfuran-2- carboxamide (other names: furanyl fentanyl) UU. 3-Furanyl fentanyl (N- (1-phenethylpiperidin-4-yl)-N- phenylfuran-3-carboxamide)
21. VV. Furethidine WW. Hydroxypethidine
22. XX. N-(1-phenethylpiperidin- 4-yl)-N-phenylisobutyramide (other name: isobutyryl fentanyl) YY. Isotonitazene (N,N-diethyl-2-(2- (4-isopropoxybenzyl)-5-nitro- 1H-benzimidazol-1-yl) ethan-1-amine) ZZ. Isovaleryl fentanyl (3-methyl- N-(1-phenethylpiperidin-4-yl)- N-phenylbutanamide) AAA. Ketobemidone BBB. Levomoramide
23. CCC. Levophenacylmorphan
24. DDD. meta-Fluorofentanyl (N- (3-fluorophenyl)-N- (1-phenethylpiperidin-4-yl) propionamide) EEE. meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N- (1-phenethylpiperidin-4-yl) isobutyramide) FFF. Methoxyacetyl fentanyl (2-methoxy-N-(1- phenethylpiperidin-4-yl)- N-phenylacetamide GGG. 2-Methyl AP–237 (1-(2-methyl- 4-(3-phenylprop-2-en-1-yl) piperazin-1-yl)butan-1-one) HHH. 4'-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl) piperidin-4-yl)-N- phenylacetamide)
25. III. 3-Methylfentanyl (N-(3- methyl-1-(2-phenylethyl)-4- piperidyl)-N- phenylproanamide), its optical and geometric isomers, salts, and salts of isomers JJJ. 3-Methylthiofentanyl (N- (3-methyl-1-(2- thienyl)ethyl-4-piperidinyl)- N-phenylpropanamide) KKK. Metonitazene (N,N-diethyl- 2-(2-(4-methoxybenzyl)-5-nitro-1H- benzimidazol-1-yl)ethan-1-amine)
26. LLL. Morpheridine
27. MMM. MPPP (1-methyl-4-phenyl-4- propionoxypiperidine) NNN. MT–45 (1-cyclohexyl- 4-(1,2-diphenylethyl) piperazine) OOO. Noracymethadol PPP. Norlevorphanol QQQ. Normethadone RRR. Norpipanone SSS. 2-(4-ethoxybenzyl)-5-nitro-1- (2-(pyrrolidin-1-yl)ethyl)-1H- Benzimidazole (other names: N-pyrrolidino etonitazene; etonitazepyne) TTT. N-(2-fluorophenyl)-2-methoxy-N-(1- phenethylpiperidin-4- yl)acetamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other name: ocfentanil) UUU. ortho-Fluoroacryl fentanyl (N-(2- fluorophenyl)-N-(1- phenethylpiperidin-4-yl) acrylamide)
28. VVV. ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl) butyramide (other name: 2-fluorobutyryl fentanyl) WWW. ortho-Fluorofentanyl (N-(2- fluorophenyl)-N-(1- phenethylpiperidin-4-yl) propionamide); other name: 2-fluorofentanyl)
29. XXX. ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)- N-(1-phenethylpiperidin-4-yl) furan-2-carboxamide) YYY. ortho-Fluoroisobutyryl fentanyl (N-(2- fluorophenyl)-N-(1- phenethylpiperidin-4- yl)isobutyramide) ZZZ. ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1- phenethylpiperidin-4-yl) acetamide (other name: 2-methyl acetylfentanyl) (9560) AAAA. ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2- methylphenyl)-N-(1- phenethylpiperidin-4-yl) acetamide (other name: 2-methyl methoxyacetyl fentanyl) BBBB. N-(4-chlorophenyl)-N- (1-phenethylpiperidin- 4-yl)isobutyramide (other name: parachloroisobutyryl fentanyl)
30. CCCC. para-Fluorobutyryl fentanyl (N-(4- fluorophenyl)-N-(1- phenethylpiperidin-4- yl)butyramide)
31. DDDD. para-Fluorofentanyl(N- (4-fluorophenyl)-N-(1-(2- phenethyl)-4-piperidinyl) propanamide EEEE. para-Fluoro furanyl fentanyl (N-(4- fluorophenyl)-N-(1- phenethylpiperidin-4- yl)furan-2-carboxamide) FFFF. para-Methoxybutyryl fentanyl (N-(4- methoxyphenyl)-N-(1- phenethylpiperidin-4-yl) butyramide) GGGG. para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)- N-(1-phenethylpiperidin-4-yl) furan-2-carboxamide HHHH. para-Methylcyclopropyl fentanyl (N-(4-methylphenyl)- N-(1-phenethylpiperidin-4-yl) cyclopropanecarboxamide)
32. IIII. para-Methylfentanyl (N-(4-methylphenyl)-N- (1-phenethylpiperidin-4-yl) propionamide (other name: 4-methylfentanyl) JJJJ. PEPAP (1-(-2-phenethyl)- 4-phenyl-4-acetoxypiperidine) KKKK. Phenadoxone
33. LLLL. Phenampromide

34. MMMM. Phenomorphan NNNN. Phenoperidine OOOO. Phenyl fentanyl (N-(1- phenethylpiperidin-4-yl)- N-phenylbenzamide (other name: benzoyl fentanyl) PPPP. Piritramide QQQQ. Proheptazine RRRR. Properidine SSSS. Propiram TTTT. N, N-diethyl-2-(5-nitro-2- (4-propoxybenzyl)-1H-benzimidazol- 1-yl)ethan-1-amine (other name: Protonitazene) UUUU. Racemoramide

    1. 2. Opium derivatives. Unless specifically excepted or

    unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible

9837 within the specific chemical designation:

9642 3. Hallucinogenic substances. Unless specifically excepted 9643 or unless listed in another schedule, any material, compound, 9644 mixture or preparation, which contains any quantity of the 9649 following hallucinogenic substances or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (For purposes of paragraph (1)(A)3. of this rule only, the term isomer includes the optical, position, and geometric isomers.): VVVV. N-(1-phenethylpiperidin-4-yl)- N-phenyltetrahydrofuran- 2-carboxamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (other name: tetrahydrofuranyl fentanyl) WWWW. Thiofentanyl (N-phenyl- N-(1-(2-thienyl)ethyl-4- piperidinyl)-propanamide XXXX. Thiofuranyl fentanyl (N-(1-phenethylpiperidin- 4-yl)-N-phenylthiophene- 2-carboxamide (other names: 2-thiofuranyl fentanyl; thiophene fentanyl) YYYY. Tilidine ZZZZ. Trimeperidine AAAAA. U–47700 (3,4-Dichloro- N-[2-(dimethylamino) cyclohexyl]-N- methylbenzamide) BBBBB. N-(1-phenethylpiperidin- 4-yl)-N-phenylpentanamide (other name: valeryl fentanyl) CCCCC. Zipeprol (1-methoxy-3-[4- (2-methoxy-2-phenylethyl) piperazin-1-yl]-1-phenylpropan-2-ol)

1. A. Acetorphine
2. B. Acetyldihydrocodeine
3. C. Benzylmorphine
4. D. Codeine methylbromide
5. E. Codeine-N-Oxide
6. F. Cyprenorphine
7. G. Desomorphine
8. H. Dihydromorphine
9. I. Drotebanol
10. J. Etorphine (except hydrochloride salt)
11. K. Heroin
12. L. Hydromorphinol
13. M. Methyldesorphine
14. N. Methyldihydromorphine
15. O. Morphine methylbromide
16. P. Morphine methylsulfonate
17. Q. Morphine-N-Oxide
18. R. Myrophine
19. S. Nicocodeine
20. T. Nicomorphine
21. U. Normorphine
22. V. Pholcodine

23. W. Thebacon

    1. A. Alpha-ethyltryptamine

Some trade or other names: etryptamine; Monase; alpha-ethyl- 1H-indole-3-ethenamine; 3-(2-aminobutyl)indole; alpha-ET; and AET;

1. B. 4-bromo-2,5-dimethoxyamphetamine

Some trade or other names: 4-bromo-2, 5- dimethoxy-amethylphenethylamine; 4-bromo- 2, 5-DMA;

1. C. 4-bromo-2,5-dimethoxyphenethylamine
2. D. 2,5-dimethoxyamphetamine

Some trade or other names: 2,5-dimethoxyamethylphenethylamine; 2,5-DMA;

1. E. 2,5-dimethoxy-4-ethylamphetamine

Some trade or other names: DOET;

1. F. 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7)
2. G. 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P)
3. H. 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E)
4. I. 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)
5. J. 2-(2,5-Dimethoxy-4-nitrophenyl) ethanamine (2C-N)
6. K. 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)
7. L. 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)
8. M. 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2)
9. N. 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)
10. O. 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4)
11. P. 4-methoxyamphetamine

Some trade or other names: 4-methoxy-amethylphenethylamine; paramethoxyamphetamine; PMA;

1. Q. 5-methoxy-3,4- methylenedioxyamphetamine
2. R. 4-methyl-2,5-dimethoxyamphetamine

Some trade and other names: 4-methyl-2, 5- dimethoxy-amethylphenethylamine; DOM; and STP;

1. S. 3,4-methylenedioxyamphetamine
2. T. 3,4-methylenedioxymethamphetamine(MDMA)
3. U. 3,4-methylenedioxy-N- ethylamphetamine (also known as N-ethylalphamethyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA, MDE, and MDEA)
4. V. N-hydroxy-3,4- methylenedioxyamphetamine (also known as N-hydroxyalpha-methyl-3,4 (methylenedioxy) phenethylamine and N- hydroxy MDA)
5. W. 3,4,5-trimethoxyamphetamine
6. X. 5-MeO-DMT or 5-methoxy- N,N-dimethyltryptamine
7. Y. Alpha-methyltryptamine
8. Z. Bufotenine

Some trade and other names: 3-(b-Dimethylaminoethyl)- 5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N-dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine; mappine; Some trade and other names: N, N-Diethyltryptamine; DET;

Some trade or other names: DMT;

Some trade and other names: 7-Ethyl- 6,6β,7,8,9,10,12,13- octahydro-2-methoxy-6, azepino[5,4-b] indole; Tabernanthe iboga;

Some trade or other names: marijuana;

Some trade or other names: 3-Hexyl-1- hydroxy-7,8,9,10- tetrahydro-6,6,9-trimethyl- 6H-dibenzo[b,d]pyran; Synhexyl;

Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds, or extracts;

a plant of the genus Cannabis (cannabis 7370 plant), as well as synthetic equivalents of the substances contained in the cannabis plant or in the resinous extractives of such plant,

7518 and/or synthetic substances, derivatives, and their isomers, or both, with similar chemical structure and pharmacological 7532 activity to those substances contained in the plant, such as the 7411 following:

isomers;

optical isomers;

optical isomers; and

internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions are covered;

Some trade or other names: N-ethyl-1- phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;

Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine PCPy, PHP;

Some trade or other names: 1-(1-(2-thienyl)- cyclohexyl)- piperidine, 2-thienyl analog of phencyclidine, TPCP, TCP;

Some other names: TCPy;

N,

AA. Diethyltryptamine

BB. Dimethyltryptamine

1. CC. 5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeODIPT)

2. DD. Ibogaine

   9-methano-5H-pyrido

EE. Lysergic acid diethylamide FF. Marihuana

GG. Mescaline HH. Parahexyl

1. II. Peyote

JJ. N-ethyl-3-piperidyl benzilate KK. N-methyl-3-piperidyl benzilate LL. Psilocybin MM. Psilocyn NN. Tetrahydrocannabinols naturally contained

1. (I) 1 cis or trans tetrahydrocannabinol and their optical
2. (II) 6 cis or trans tetrahydrocannabinol and their
3. (III) 3,4 cis or trans tetrahydrocannabinol and its
4. (IV) Since nomenclature of these substances is not

OO. Ethylamine analog of phencyclidine

ethylamine, N-(1-phenylcyclohexyl)-

PP. Pyrrolidine analog of phencyclidine

QQ. Thiophene analog of phencyclidine

RR. 1-(1-(2-thienyl)cyclohexyl) pyrrolidine

SS. Salvia divinorum TT. Salvinorin A UU. 3-Fluoromethcathinone VV. 4-Fluoromethcathinone WW. Mephedrone, or 4- methylmethcathinone XX. Methylenedioxypyrovalerone, MDPV, or (1-(1,3-Benzodioxol-5-yl)- 2-(1-pyrrolidinyl)-1- pentanone [1’,2’:1,2]

in

YY. Methylone, or 3,4- Methylenedioxymethcathinone ZZ. Quinolin-8-yl 1-pentyl- 1Hindole-3-carboxylate (PB-22; QUPIC) AAA. Quinolin-8-yl 1-(5- fluoropentyl)-1H-indole- 3-carboxylate (5-fluoro- PB-22; 5F-PB-22) BBB. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1- (4-fluorobenzyl)-1Hindazole- 3-carboxamide (AB-FUBINACA) CCC. N-(1-amino-3, 3-dimethyl-1- oxobutan-2-yl)-1-pentyl- 1H-indazole-3-carboxamide (ADB-PINACA) DDD. (1-pentyl-1H-indol-3-yl) (2,2,3,3-tetramethylcyclopropyl) methanone (other names: UR-144, 1-pentyl-3-(2,2,3,3- tetramethylcyclopropoyl)indole) EEE. [1-(5-fluoro-pentyl)- 1Hindol-3-yl](2,2,3,3- tetramethylcyclopropyl) methanone (other names: 5-fluoro-UR-144, 5-F-UR- 144, XLR11, 1-(5-fluoropentyl)-3-(2,2,3,3- tetramethylcyclopropoyl)indole) FFF. N-(1-adamantyl)-1-pentyl- 1Hindazole-3-carboxamide (other names: APINACA, AKB48) GGG. 2-(4-iodo-2,5- dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (other names: 251-NBOMe; 2C-I- NBOMe; 25I; Cimbi-5) HHH. 2-(4-chloro-2,5- dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (other names: 25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82) III. 2-(4-bromo-2,5- dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (other names: 25B- NBOMe; 2C-B-NBOMe; 25B; Cimbi-36) JJJ. 4-methyl-N-ethylcathinone (other names: 4-MEC; 2- (ethylamino)-1-(4- methylphenyl)propan-1-one) KKK. 4-methyl-alphapyrrolidinopropiophenone, (other names: 4-MePPP; MePPP; 4-methyl- α-pyrrolidinopropiophenone; 1-(4-methylphenyl)-2- (pyrrolidin-1-yl)-propan-1-one) LLL. alphapyrrolidinopentiophenone (other names: α-PVP; α- pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one) 7545 MMM. Butylone (other names: bk-MBDB; 1-(1,3- benzodioxol-5-yl)-2- (methylamino)butan-1-one) 7541 NNN. Pentedrone (other names: α- methylaminovalerophenone; 2-(methylamino)-1-phenylpentan-1-one) 1246 OOO. Pentylone (other names: bk-MBDP; 1-(1,3- benzodioxol-5-yl)-2- (methylamino)pentan-1-one) 7542 PPP. Naphyrone (other names: naphthylpyrovalerone; 1- (naphthalen-2-yl)-2- (pyrrolidin-1-yl)pentan-1-one) 1258 QQQ. alpha-pyrrolidinobutiophenone (other names: α-PBP; 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one) 7546 RRR. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1- (cyclohexylmethyl)- 1H-indazole-3-carboxamide (other names: AB-CHMINACA) 7031 SSS. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1-pentyl- 1Hindazole-3-carboxamide (other names: AB-PINACA) 7023 TTT. [1-(5-fluoropentyl)- 1H-indazol-3-yl](naphthalen- 1-yl)methanone (other names: THJ-2201) 7024 UUU. N-(1-amino-3,3-dimethyl- 1-oxobutan-2-yl)-1- (cyclohexylmethyl)- 1H-indazole-3-carboxamide (other names: MAB- CHMINACA; ADB-CHMINACA) 7032 VVV. methyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-carboxamido)-3,3- dimethylbutanoate (other names: 5F–ADB; 5F–MDMB–PINACA) 7034 WWW. methyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-carboxamido)-3- methylbutanoate (other names: 5F–AMB) 7033 XXX. N-(adamantan-1-yl)-1-(5- fluoropentyl)-1H-indazole- 3-carboxamide (other names: 5F–APINACA, 5F– AKB48) 7049 YYY. N-(1-amino-3,3-dimethyl- 1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole- 3-carboxamide (other names: ADB–FUBINACA) 7010 ZZZ. methyl 2-(1-(cyclohexylmethyl)- 1H-indole-3-carboxamido)-3,3- dimethylbutanoate (other names: MDMB–CHMICA, MMB–CHMINACA) 7042 AAAA. methyl 2-(1-(4-fluorobenzyl)- 1H-indazole-3-carboxamido)-3,3- dimethylbutanoate (other names: MDMB–FUBINACA) BBBB. methyl 2-(1-(4-fluorobenzyl)-1H- indazole-3-carboxamido)-3- methylbutanoate (other names: FUB–AMB, MMB– FUBINACA, AMB–FUBINACA) CCCC. 1-(1,3-benzodioxol- 5-yl)-2-(ethylamino) propan-1-one (ethylone) DDDD. Naphthalen-1-yl 1- (5-fluoropentyl)-1H- indole-3-carboxylate (other names: NM2201; CBL2201) EEEE. N-(1-amino-3-methyl- 1-oxobutan-2-yl)-1- (5-fluoropentyl)-1H- indazole-3-carboxamide (other name: 5F-AB-PINACA) FFFF. 1-(4-cyanobutyl)-N-(2- phenylpropan-2-yl)-1H- indazole-3-carboxamide (other names: 4-CN- CUMYLBUTINACA; 4-cyano-CUMYL- BUTINACA; 4-CN- CUMYLBINACA; CUMYL-4CNBINACA; SGT-78) GGGG. methyl 2-(1-(cyclohexylmethyl)-1H- indole-3-carboxamido)-3- methylbutanoate (other names: MMB- CHMICA; AMB-CHMICA) HHHH. 1-(5-fluoropentyl)-N- (2-phenylpropan-2-yl)- 1H-pyrrolo[2,3-b] pyridine-3-carboxamide (other name: 5F-CUMYL-P7AICA) IIII. N-ethylpentylone (other names: ephylone, 1-(1,3- benzodioxol-5-yl)-2- (ethylamino)-pentan-1-one) JJJJ. methyl 2-(1-(4-fluorobutyl)- 1H-indazole-3-carboxamido)-3, 3-dimethylbutanoate (4F–MDMB–BINACA, 4F–MDMB–BUTINACA) KKKK. 1-(4-methoxyphenyl)-N- methylpropan-2-amine (other names: paramethoxymethamphetamine, PMMA) LLLL. ethyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-carboxamido)-3,3- dimethylbutanoate (other name: 5F-EDMB-PINACA) MMMM. methyl 2-(1-(5-fluoropentyl)- 1H-indole-3-carboxamido)-3,3- Dimethylbutanoate (other names: 5F-MDMB-PICA; 5F-MDMB-2201) NNNN. N-(adamantan-1-yl)-1-(4- fluorobenzyl)-1H-indazole-3- carboxamide (other names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL)) (7021)

exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

3-(1-naphthoyl)indole or by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Including, but not limited to:

OOOO. 1-(5-fluoropentyl)-N-(2- phenylpropan-2-yl)-1H- indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25) PPPP. (1-(4-fluorobenzyl)-1H- indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone (other name: FUB-144) QQQQ. N-Ethylhexedrone (other names: α-ethylaminohexanophenone; 2- (ethylamino)-1-phenylhexan-1-one) RRRR. alpha-Pyrrolidinohexanophenone (other names: α-PHP; α- pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1- one) SSSS. 4-Methyl-alpha-ethylaminopentiophenone (other names: 4-MEAP; 2-(ethylamino)-1- (4-methylphenyl)pentan-1-one) TTTT. 4'-Methyl-alpha-pyrrolidinohexiophenone (other names: MPHP; 4'-methylalpha-pyrrolidinohexanophenone; 1- (4-methylphenyl)-2-(pyrrolidin-1-yl)hexan- 1-one) UUUU. alpha-Pyrrolidinoheptaphenone (other names: PV8; 1-phenyl-2- (pyrrolidin-1-yl)heptan-1-one) VVVV. 4'-Chloro-alpha-pyrrolidinovalerophenone (other names: 4-chloro-α-PVP; 4'-chloro-α- pyrrolidinopentiophenone; 1-(4- chlorophenyl)-2-(pyrrolidin-1-yl) pentan- 1-one) WWWW. 2-(ethylamino)-2- (3-methoxyphenyl)cyclohexan- 1-one (methoxetamine, MXE) XXXX. 1-(1,3-benzodioxol-5-yl)-2-9 (ethylamino)butan-1-one (other names: eutylone; bk-EBDB) YYYY. N-(1-amino-3,3-dimethyl-1- oxobutan-2-yl)-1-butyl-1H- indazole-3-carboxamide (other name: ADB–BUTINACA) ZZZZ. 4-methyl-1-phenyl-2- (pyrrolidin-1-yl)pentan-1-one (other names: α-PiHP; alpha-PiHP) AAAAA. 2-(methylamino)-1-(3- methylphenyl)propan-1-one (other names: 3–MMC; 3-methylmethcathinone) BBBBB. Synthetic cannabinoids: Unless specifically

1. (I) Any compound structurally derived 1Hindol-3-yl-(1-naphthyl)methane

   2-(4-morpholinyl)ethyl

   1. (a) AM2201, or 1-(5-fluoropentyl)-3- (1-naphthoyl)indole from

      1. (b) JWH-007, or 1-pentyl-2-methyl-
      2. (c) JWH-015, or 1-propyl-2-methyl-3-(1-
      3. (d) JWH-018, or 1-pentyl-
      4. (e) JWH-019, or 1-hexyl-
      5. (f) JWH-073, or 1-butyl-
      6. (g) JWH-081, or 1-pentyl-3-(4-methoxy-1-
      7. (h) JWH-098, or 1-pentyl-2-methyl-3-(4-
      8. (i) JWH-122, or 1-pentyl-3-(4-methyl-1-
      9. (j) JWH-164, or 1-pentyl-3-(7-methoxy-1-
      10. (k) JWH-200, or 1-(2-(4-(morpholinyl)ethyl))-
      11. (l) JWH-210, or 1-pentyl-3-(4-ethyl-1-
      12. (m) JWH-398, or 1-pentyl-3-(4-chloro-1-
      13. (II) Any compound

3-(1-naphthoyl)pyrrole by atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent;

1. (III) Any compound

1-(1-naphthylmethyl)indene 3-position of the indene ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent;

1. (IV) Any compound structurally derived

3-phenylacetylindole by atom of the indole ring with alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent. Including, but not limited to:

1. (a) JWH-201, or 1-pentyl-3-(4-
2. (b) JWH-203, or 1-pentyl-3-(2-chloropheny-
3. (c) JWH-250, or 1-pentyl-
4. (d) JWH-251, or 1-pentyl-3-(2-
5. (e) RCS-8, or 1-(2-cyclohexylethyl)-3-(2-
6. (V) Any compound

2-(3-hydroxycyclohexyl)phenol 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to:

1. (a) CP 47,497 and homologues, or 2-[(1R,3S)-3-

hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol), where side chain n=5, and homologues where side chain n-4, 6, or 3-(1-naphthoyl)indole

naphthoyl)indole

3-(1-naphthoyl)indole

3-(1-naphthoyl)indole

3-(1-naphthoyl)indole

naphthoyl)indole

methoxy-1-naphthoyl)indole

naphthoyl)indole

naphthoyl)indole

3-(1-naphthoyl)indole

naphthoyl)indole

naphthoyl)indole structurally derived substitution at the nitrogen

structurally derived

by substitution

substitution at the nitrogen

methoxyphenylacetyl)indole

lacetyl)indole

3-(2-methoxypheny-lacetyl)indole

methylphenylacetyl)indole

methoxypheny-lacetyl)indole structurally derived by substitution

7297, 7298

structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 2-(4-morpholinyl)ethyl group, whether or not substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not

7019 limited to:

methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10aoctahydrophenanthridin- 1-yl] acetate;

dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] chromen-1-ol;

(hydroxymethyl)- 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;

1. 4. Depressants. Unless specifically excepted or unless

from listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: from

at the

1. 5. Stimulants. Unless specifically excepted or unless listed

in another schedule, any material, compound, mixture, or

from preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:

Some trade or other names: aminoxaphen; 2-amino-5-phenyl- 2-oxazoline; 4,5-dihydro-5-phenyl-2-oxazolamine;

from

at the (VI) Any compound containing a 3- (benzoyl)indole

1-(N-methyl-2-piperidinyl)methyl or further

1. (a) AM-694, or 1-(5-fluoropentyl)-3-(2- iodobenzoyl)indole 7694
2. (b) RCS-4, or 1-pentyl-3-(4- methoxybenzoyl)indole (SR-19 and RCS-4) 7104
3. (VII) CP 50,556-1, or [(6S,6aR,9R,10aR)-9-hydroxy-6-

(VIII) HU-210, or (6aR,10aR)-9-(hydroxymethyl)-6,6-

1. (IX) HU-211, or Dexanabinol,(6aS,10aS)-9- 6,6-dimethyl-3-(2-methyloctan-2-yl)-
2. (X) Dimethylheptylpyran, or DMHP.

1. A. Gamma-hydroxybutyric acid and other names GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutonic acid; sodium oxybate; sodium oxybutryrate 2010
2. B. Mecloqualone 2572
3. C. Methaqualone 2565
4. A. Amineptine (7-[(10,11-dihydro-5H- dibenzo[a,d]cyclohepten-5-yl)amino] heptanoic acid) 1219
5. B. Aminorex 1585
6. C. N-benzylpiperazine (some other names: BZP, 1- benzylpiperzaine) 7493
7. D. Cathinone (Some trade or other names: 2-amino-1- phenyl-1-propanone, alphaaminopropiophenone, 2-aminopropiophenone and norephedrone) 1235
8. E. 4,4'-Dimethylaminorex (4,4'-DMAR; 4,5-dihydro-4- methyl-5-(4-methylphenyl)-2- oxazolamine; 4-methyl-5-(4- methylphenyl)-4,5-dihydro- 1,3-oxazol-2-amine) 1595
9. F. Fenethylline 1503

10. G. Mesocarb (N-phenyl-N'-(3- (1-phenylpropan-2-yl)-1,2,3-oxadiazol- 3-ium-5-yl)carbamimidate) 1227

    1. H. Methcathinone

Some trade or other names: 2-(methylamino)-propiophenone; alpha-(methylamino) propiophenone; 2-(methylamino)-1- phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinine; AL-464; AL-422; AL-463 and URI 432;

1. I. Methiopropamine (N-methyl-1- (thiophen-2-yl)propan-2-amine)
2. J. 4-methoxymethcathinone
3. K. cis-4-methylaminorex (cis-4,5-dihydro-4-methyl- 5-phenyl-2-oxazolamine)
4. L. 4-Methyl-alphapyrrolidinobutiophenone, or MPBP
5. M. N-ethylamphetamine
6. N. N,N-dimethylamphetamine

(some other names: N,N-alpha-trimethylbenzeneethanamine; N,N-alpha-trimethylphenethylamine)

1. 6. A temporary listing of substances subject to emergency

scheduling under federal law shall include any material, compound, mixture, or preparation which contains any quantity of the following substances:

1. A. Fentanyl-related substances, their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers.

   1. (I) Fentanyl-related substance means any substance

not otherwise listed under another Administration Controlled Substance Code Number, and for which no exemption or approval is in effect under section 505 of the Federal Food, Drug, and Cosmetic Act 21 U.S.C. 355, that is structurally related to fentanyl by one (1) or more of the following modifications:

1. (a) Replacement of the phenyl portion of the

phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;

1. (b) Substitution in or on the phenethyl group with

alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino, or nitro groups;

1. (c) Substitution in or on the piperidine ring with

alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino, or nitro groups;

1. (d) Replacement of the aniline ring with any

aromatic monocycle whether or not further substituted in or on the aromatic monocycle; and/or

1. (e) Replacement of the N-propionyl group by

another acyl group.

1. B. 2-(2-(4-butoxybenzyl)-5-nitro-1H- benzimidazol-1-yl)-N, N-diethylethan-1- amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Butonitazene)
2. C. N, N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro- 1H-benzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Flunitazene)
3. D. N,N-diethyl-2-(2-(4-methoxybenzyl)-1H- benzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: Metodesnitazene)

4. E. 4-(2-chlorophenyl)-2-ethyl-9- methyl-6H-thieno[3,2-f][1,2,4]triazolo [4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (other name: etizolam)

   1. 7. Khat, to include all parts of the plant presently classified

   botanically as catha edulis, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or

1. F. 8-chloro-6-(2-fluorophenyl)-1- methyl-4H-benzo[f][1,2,4]triazolo [4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (other name: flualprazolam)
2. G. 6-(2-chlorophenyl)-1-methyl-8- nitro-4H-benzo[f][1,2,4]triazolo [4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (other name: clonazolam)
3. H. 8-bromo-6-(2-fluorophenyl)-1- methyl-4H-benzo[f][1,2,4]triazolo [4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (other name: flubromazolam)
4. I. 7-chloro-5-(2-chlorophenyl)-1- methyl-1,3-dihydro-2Hbenzo [e][1,4]diazepin-2-one, its salts, isomers, and salts of isomers (other name: diclazepam)
5. J. Methyl 3,3-dimethyl-2- (1-(pent-4-en-1-yl)-1H-indazole- 3-carboxamido)butanoate, its optical and geometric isomers, salts and salts of isomers (other name: MDMB–4en–PINACA)
6. K. Methyl 2-[[1-(4-fluorobutyl) indole-3-carbonyl]amino]-3,3- dimethyl-butanoate, its optical and geometric isomers, salts and salts of isomers (other names: 4F–MDMB–BUTICA; 4F–MDMB–BICA)
7. L. N-(1-Amino-3,3-dimethyl-1-oxobutan- 2-yl)-1-(pent-4-en-1-yl)-1H-indazole- 3-carboxamide, its optical and geometric isomers, salts and salts of isomers (other name: ADB–4en–PINACA)
8. M. 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido [4,3-b]indol-1-one, its optical and geometric isomers, salts and salts of isomers (other names: CUMYL–PEGACLONE; SGT–151)
9. N. Ethyl 2-[[1-(5-fluoropentyl)indole-3- carbonyl]amino]-3,3-dimethyl-butanoate, its optical and geometric isomers, salts and salts of isomers (other names: 5F–EDMB–PICA; 5F–EDMB–2201)
10. O. Methyl 2-(1-(4-fluorobenzyl)-1H-indole- 3-carboxamido)-3-methyl butanoate, its optical and geometric isomers, salts and salts of isomers (other name: MMB–FUBICA)
11. P. N-ethyl-2-(2-(4-isopropoxybenzyl)-5- nitro-1H-benzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other name: N-desethyl isotonitazene)

12. Q. 2-(4-ethoxybenzyl)-5-nitro-1-(2- (piperidin-1-yl)ethyl)-1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (other names: N-piperidinyl etonitazene; etonitazepipne) 9761 preparation of the plant, its seed, or extracts.

    1. (B) Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Controlled Substances Code Number set forth opposite it.

       1. 1. Substances, vegetable origin, or chemical synthesis.

Unless specifically excepted or unless listed in another schedule, Schedule II shall include any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis:

1. A. Opium and opiate; and any salt, compound,

derivative, or preparation of opium or opiate, excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene, naloxegol, naloxone, and naltrexone and their respective salts, but including the following:

1. (I) Raw opium
2. (II) Opium extracts
3. (III) Opium fluid
4. (IV) Powdered opium
5. (V) Granulated opium
6. (VI) Tincture of opium
7. (VII) Codeine (VIII) Dihydroetorphine
8. (IX) Ethylmorphine
9. (X) Etorphine hydrochloride
10. (XI) Hydrocodone
11. (XII) Hydromorphone (XIII) Metopon
12. (XIV) Morphine
13. (XV) Oripavine
14. (XVI) Oxycodone (XVII) Oxymorphone (XVIII) Thebaine
15. B. Any salt, compound, derivative, or preparation

thereof which is chemically equivalent or identical with any of the substances referred to in subparagraph (1)(B)1.A. of this rule shall be included in Schedule II, except that these substances shall not include the isoquinoline alkaloids of opium;

1. C. Opium poppy and poppy straw
2. D. Coca leaves (9040) and any salt, compound, derivative,

or preparation of coca leaves (including cocaine (9041) and ecgonine (9180) and their salts, isomers, derivatives, and salts of isomers and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include—

1. (I) Decocainized coca leaves or extraction of coca

leaves, which extractions do not contain cocaine or ecgonine; or

1. (II) Ioflupane;
2. E. Concentrate of poppy straw (the crude extract

of poppy straw in either liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy)

1. 2. Opiates. Unless specifically excepted or unless in

another schedule any of the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan, and levopropoxyphene excepted:

1. A. Alfentanil
2. B. Alphaprodine

3. C. Anileridine Some other names: levo-alphaacetylmethadol, levomethadyl acetate, LAAM

   1. 3. Stimulants. Unless specifically excepted or unless listed

9650 in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:

1. 4. Depressants. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following

9670 substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. 5. Hallucinogenic substances:

1. D. Bezitramide
2. E. Bulk Dextropropoxyphene (Non-dosage Forms)
3. F. Carfentanil
4. G. Dihydrocodeine
5. H. Diphenoxylate
6. I. Fentanyl
7. J. Isomethadone
8. K. Levo-alphacetylmethadol
9. L. Levomethorphan
10. M. Levorphanol
11. N. Metazocine
12. O. Methadone
13. P. Methadone-Intermediate, 4-cyano-2-dimethylamino- 4,4-diphenyl butane
14. Q. Moramide-Intermediate, 2- methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid
15. R. Oliceridine (N-[(3-methoxythiophen-2-yl) methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl})amine fumarate)
16. S. Pethidine (Meperidine)
17. T. Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine
18. U. Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate
19. V. Pethidine-Intermediate-C, 1- methyl-4-phenylpiperidine- 4-carboxylic acid
20. W. Phenazocine
21. X. Piminodine
22. Y. Racemethorphan
23. Z. Racemorphan AA. Remifentanil BB. Sufentanil
24. CC. Tapentadol
25. DD. Thiafentanil
26. A. Amphetamine, its salts, optical isomers, and salts of its optical isomers
27. B. Lisdexamfetamine, its salts, isomers, and salts of its isomers
28. C. Methamphetamine, its salts, isomers, and salts of its isomers
29. D. Phenmetrazine and its salts
30. E. Methylphenidate
31. A. Amobarbital
32. B. Glutethimide
33. C. Pentobarbital
34. D. Phencyclidine

35. E. Secobarbital

    1. A. Nabilone

Another name for nabilone: (±)trans-3-(1, 1- dimethylheptyl)-6, 6a,7,8,10,10a-hexahydro- 1-hydroxy-6, 6-dimethyl-9H- dibenzo(b,d) pyran-9-one.

1. B. Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in

an oral solution in a drug product approved for marketing by the United States Food and Drug Administration.

1. 6. Immediate precursors. Unless specifically excepted or

unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:

1. A. Immediate precursor to amphetamine

methamphetamine:

1. (I) Phenylacetone

Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone;

1. B. Immediate precursors to phencyclidine (PCP):

   1. (I) 1-phenylcyclohexylamine
   2. (II) 1-piperidinocyclohexanecarbonitrile (PCC)

2. C. Immediate precursor to fentanyl:

   1. (I) 4-anilino-N-phenethyl-4- piperidine (ANPP)
   2. (II) N-phenyl-N-(piperidin- 4-yl)propionamide (norfentanyl)
3. 7. Any material, compound, mixture, or preparation which

contains any quantity of the following alkyl nitrites:

1. A. Amyl nitrite;
2. B. Butyl nitrite.

3. (C) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.

   1. 1. Stimulants. Unless specifically excepted or unless listed

in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. A. Those compounds, mixtures, or preparations in

dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under 21 CFR 308.32 and any other drug of the quantitive composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances

1. B. Benzphetamine
2. C. Chlorphentermine
3. D. Clortermine
4. E. Phendimetrazine
5. 2. Depressants. Unless specifically excepted or unless

listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:

1. A. Any compound, mixture, or preparation containing—

   1. (I) Amobarbital
   2. (II) Secobarbital
   3. (III) Pentobarbital

or any salt thereof and one (1) or more other active medicinal ingredients which are not listed in any schedule;

1. B. Any suppository dosage form containing— or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository;

(7365) derivative of barbituric acid or any salt thereof

acid, including its salts, isomers, and salts of isomer, for which

and an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act;

Some trade or other names for a tiletaminezolazepam combination product: Telazol. Some trade or other names for tiletamine: 2- (ethylamino)-2-(2- thienyl)-cyclohexanone. Some trade or other names for zolazepam: 4-(2-fluorophenyl)- 6-8-dihydro-1,3,8- trimethylpyrazolo-(3,4-e) (1,4)-diazepin- 7(1H)- one, flupyrazapon.

1. 3. Nalorphine
2. 4. Narcotics drugs. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof:

of codeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium

codeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

1228 of dihydrocodeine per one hundred milliliters (100 mL) or not 1645 more than ninety milligrams (90 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

of ethylmorphine per one hundred milliliters (100 mL) or not more than fifteen milligrams (15 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts

2126 opium per one hundred milliliters (100 mL) or per one hundred 2316 grams (100 gm) or not more than twenty-five milligrams (25 2271 mg) per dosage unit, with one (1) or more active nonnarcotic ingredients in recognized therapeutic amounts

per one hundred milliliters (100 mL) or per one hundred grams

1. (I) Amobarbital
2. (II) Secobarbital
3. (III) Pentobarbital

1. C. Any substance which contains any quantity of a
2. D. Chlorhexadol
3. E. Embutramide
4. F. Any drug product containing gamma hydroxybutyric
5. G. Ketamine, its salts, isomer, and salts of isomers (some other names for ketamine: (±)-2-(2-chlorophenyl)-2-(methylamino)- cyclohexanone)
6. H. Lysergic acid
7. I. Lysergic acid amide
8. J. Methyprylon
9. K. Perampanel, and its salts, isomers, and salts of isomers
10. L. Sulfondiethylmethane
11. M. Sulfonethylmethane
12. N. Sulfonmethane
13. O. Tiletamine and zolazepam or any salt thereof
14. A. Not more than one and eight-tenths grams (1.8 gm)
15. B. Not more than one and eight-tenths grams (1.8 gm) of
16. C. Not more than one and eight-tenths grams (1.8 gm)
17. D. Not more than three hundred milligrams (300 mg)
18. E. Not more than five hundred milligrams (500 mg) of

19. F. Not more than fifty milligrams (50 mg) of morphine (100 gm), with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts 9810

    1. 5. Any material, compound, mixture, or preparation

containing any of the following narcotic drugs or their salts, as set forth below:

1. A. Buprenorphine 9064
2. 6. Anabolic steroids. Unless specifically excepted or

unless listed in another schedule, any substance meeting the definition of anabolic steroid as set forth in 21 CFR 1300.01, of the August 1, 2023, Code of Federal Regulations, as published by the Office of the Federal Register, National Archives and Records Administration, 700 Pennsylvania Avenue, Washington, DC 20408, which is hereby incorporated by reference and does not include later amendments or additions, including any material, compound, mixture or preparation containing any quantity of the following substances, including its salts, esters, and ethers (4000):

1. A. 5α-androstan-3,17-dione;
2. B. 5α-androstan-3,6,17-trione;
3. C. 1-androstenediol (3β,17β-dihydroxy-5α-androst-1-ene);
4. D. 1-androstenediol (3α,17β-dihydroxy-5α-androst-1-ene);
5. E. 4-androstenediol (3β,17β-dihydroxy-androst-4-ene);
6. F. 5-androstenediol (3β,17β-dihydroxy-androst-5-ene);
7. G. 1-androstenedione (5α-androst-1-en-3,17-dione);
8. H. 4-androstenedione (androst-4-en-3,17-dione);
9. I. 5-androstenedione (androst-5-en-3,17-dione);
10. J. bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4-en-

3-one);

1. K. boldenone (17β-hydroxyandrost-1,4-diene-3-one);
2. L. boldione (androsta-1,4-diene-3,17-dione);
3. M. 6-bromo-androsta-1,4-diene-3,17-dione;
4. N. 6-bromo-androstan-3,17-dione;
5. O. calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4-

en-3-one);

1. P. 4-chloro-17α-methyl-androsta-1,4-diene-3,17β-diol;
2. Q. 4-chloro-17α-methyl-androst-4-ene-3β,17β-diol;
3. R. 4-chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one; S. 4-chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-

dione;

1. T. clostebol (4-chloro-17β-hydroxy-androst-4-en-3-one);
2. U. dehydrochloromethyltestosterone (4-chloro-17β-

hydroxy-17α-methyl-androst-1,4-dien-3-one);

1. V. desoxymethyltestosterone (17α-methyl-5α-androst-2-

en-17β-ol) (a.k.a. “madol”);

1. W. 4-dihydrotestosterone (17β-hydroxy-androstan-3-one);
2. X. Δ1-dihydrotestosterone (a.k.a. “1-testosterone”)

(17β-hydroxy-5α-androst-1-en-3-one);

1. Y. 3β,17β-dihydroxy-5α-androstane;
2. Z. 3α,17β-dihydroxy-5α-androstane; AA. 2α,17α-dimethyl-17β-hydroxy-5β-androstan-3-one; BB. drostanolone (17β-hydroxy-2α-methyl-5α-androstan-

3-one);

1. CC. 2α,3α-epithio-17α-methyl-5α-androstan-17β-ol;
2. DD. estra-4,9,11-triene-3,17-dione; EE. 13β-ethyl-17β-hydroxygon-4-en-3-one; FF. ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene); GG. fluoxymesterone (9-fluoro-17α-methyl-11β,17β-

dihydroxyandrost-4-en-3-one); HH. formebolone (2-formyl-17α-methyl-11α,17β- dihydroxyandrost-1,4-dien-3-one);

1. II. furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]

furazan); JJ. [3,2-c]furazan-5α-androstan-17β-ol; KK. 18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one;

1. LL. 4-hydroxy-19-nortestosterone (4,17β-dihydroxy-estr-4-

en-3-one);

1. MM. 4-hydroxy-androst-4-ene-3,17-dione; NN. 17β-hydroxy-androstano[2,3-d]isoxazole; OO. 17β-hydroxy-androstano[3,2-c]isoxazole; PP. 3β-hydroxy-estra-4,9,11-trien-17-one; QQ. 4-hydroxytestosterone (4,17β-dihydroxy-androst-4-

en-3-one); RR. mestanolone (17α-methyl-17β-hydroxy-5α-androstan- 3-one); SS. mesterolone (1α-methyl-17β-hydroxy-5α-androstan-3- one); TT. methandienone (17α-methyl-17β-hydroxyandrost-1,4- dien-3-one); UU. methandriol (17α-methyl-3β,17β-dihydroxyandrost-5- ene);

1. VV. methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-

3-one or 2α,17α-dimethyl-17β-hydroxy-5α-androstan-3-one); WW. methenolone (1-methyl-17β-hydroxy-5α-androst-1- en-3-one);

1. XX. 17α-methyl-androsta-1,4-diene-3,17β-diol; YY. 17α-methyl-5α-androstan-17β-ol; ZZ. 17α-methyl-androstan-3-hydroxyimine-17β-ol; AAA. 6α-methyl-androst-4-ene-3,17-dione; BBB. 17α-methyl-androst-2-ene-3,17β-diol;
2. CCC. 17α-methyl-3β,17β-dihydroxy-5α-androstane;
3. DDD. 17α-methyl-3α,17β-dihydroxy-5α-androstane; EEE. 17α-methyl-3β,17β-dihydroxyandrost-4-ene; FFF. 17α-methyl-4-hydroxynandrolone (17α-methyl-4-

hydroxy-17β-hydroxyestr-4-en-3-one); GGG. methyldienolone (17α-methyl-17β-hydroxyestra- 4,9(10)-dien-3-one); HHH. 17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy- (a.k.a. 17α-methyl-5α-androst-1-en-3-one) “17-α-methyl-1- testosterone”);

1. III. methyltestosterone (17α-methyl-17β-hydroxyandrost-

4-en-3-one); JJJ. methyltrienolone (17α-methyl-17β-hydroxyestra- 4,9,11-trien-3-one); KKK. mibolerone (7α,17α-dimethyl-17β-hydroxyestr-4-en- 3-one);

1. LLL. nandrolone (17β-hydroxyestr-4-en-3-one);
2. MMM. 19-nor-4-androstenediol (3β,17β-dihydroxyestr-4-

ene); NNN. 19-nor-4-androstenediol (3α,17β-dihydroxyestr-4- ene); OOO. 19-nor-5-androstenediol (3β,17β-dihydroxyestr-5- ene); PPP. 19-nor-5-androstenediol (3α,17β-dihydroxyestr-5- ene); QQQ. 19-nor-4,9(10)-androstadienedione (estra-4,9(10)- diene-3,17-dione); RRR. 19-nor-4-androstenedione (estr-4-en-3,17-dione); SSS. 19-nor-5-androstenedione (estr-5-en-3,17-dione); TTT. norbolethone (13β,17α-diethyl-17β-hydroxygon-4-en- 3-one); UUU. norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one);

1. VVV. norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3-

one); WWW. normethandrolone (17α-methyl-17β-hydroxyestr- 4-en-3-one);

1. XXX. oxandrolone (17α-methyl-17β-hydroxy-2-oxa-5α-

androstan-3-one); YYY. oxymesterone (17α-methyl-4,17β-dihydroxyandrost- 4-en-3-one); ZZZ. oxymetholone (17α-methyl-2-hydroxymethylene- 17β-hydroxy-5α-androstan-3-one); AAAA. prostanozol (17β-hydroxy-5α-androstano[3,2-c] pyrazole or [3,2-c]pyrazole-5α-androstan-17β-ol); BBBB. [3,2-c]pyrazole-androst-4-en-17β-ol;

1. CCCC. stanozolol (17α-methyl-17β-hydroxy-5α-androst-2-

eno[3,2-c]-pyrazole);

1. DDDD. stenbolone (17β-hydroxy-2-methyl-5α-androst-1-

en-3-one); EEEE. testolactone (13-hydroxy-3-oxo-13,17-secoandrosta- 1,4-dien-17-oic acid lactone); FFFF. testosterone (17β-hydroxyandrost-4-en-3-one); GGGG. tetrahydrogestrinone (13β,17α-diethyl-17β- hydroxygon-4,9,11-trien-3-one); and HHHH. trenbolone (17β-hydroxyestr-4,9,11-trien-3-one).

1. 7. Dronabinol (synthetic) in sesame oil and encapsulated

in a soft gelatin capsule in a United States Food and Drug Administration approved drug product (Some other names for dronabinol: (6αRtrans)- 6a,7,8,10α- tetrahydro-6.6.9-trimethyl-3-pentyl-6H-dibenzo (b,d) pyran-1- ol, or (-) -delta-9-(trans)-tetrahydrocannabinol.)

1. (D) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this subsection. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.

   1. 1. Narcotic drugs. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof:

1. A. Not more than one milligram (1 mg) of difenoxin (DEA

Drug Code No. 9168) and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit

1. B. Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-

diphenyl-3-methyl-2-propionoxybutane)

1. C. 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)

cyclohexanol, its salts, optical and geometric isomers, and salts of these isomers (including tramadol)

1. D. Narcotic drugs containing nonnarcotic active

medicinal ingredients. Any compound, mixture, or preparation containing any of the following limited quantities of narcotic drugs or salts thereof, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:

1. (I) Not more than two hundred milligrams (200 mg)

of codeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

1. (II) Not more than one hundred milligrams (100 mg) of

dihydrocodeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm); or

1. (III) Not more than one hundred milligrams (100 mg)

of ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm).

1. 2. Depressants. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. A. Alfaxalone
2. B. Alprazolam
3. C. Barbital
4. D. Brexanolone
5. E. Bromazepam

6. F. Camazepam

   1. 3. Lorcaserin. Any material, compound, mixture, or

   preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:

2882 4. Stimulants. Unless specifically excepted or unless listed 2145 in another schedule, any material, compound, mixture, or 2400 preparation which contains any quantity of the following 2748 substances having a stimulant effect on the central nervous 2749 system, including its salts, isomers, and salts of isomers: G. Carisoprodol H. Chloral betaine I. Chloral hydrate J. Chlordiazepoxide K. Clobazam L. Clonazepam M. Clorazepate N. Clotiazepam O. Cloxazolam P. Daridorexant Q. Delorazepam R. Diazepam S. Dichloralphenazone T. Estazolam U. Ethchlorvynol V. Ethinamate W. Ethyl loflazepate X. Fludiazepam Y. Flunitrazepam Z. Flurazepam AA. Fospropofol BB. Halazepam CC. Haloxazolam DD. Ketazolam EE. Lemborexant FF. Loprazolam GG. Lorazepam HH. Lormetazepam II. Mebutamate JJ. Medazepam KK. Meprobamate LL. Methohexital MM. Methylphenobarbital (Mephobarbital) NN. Midazolam OO. Nimetazepam PP. Nitrazepam QQ. Nordiazepam RR. Oxazepam SS. Oxazolam TT. Paraldehyde UU. Petrichloral VV. Phenobarbital WW. Pinazepam XX. Prazepam YY. Quazepam ZZ. Remimazolam AAA. Suvorexant BBB. Temazepam CCC. Tetrazepam DDD. Triazolam EEE. Zaleplon FFF. Zolpidem GGG. Zopiclone HHH. Zuranolone

1. A. Lorcaserin

   1. A. Cathine ((+)-norpseudoephedrine)
   2. B. Diethylpropion
   3. C. Fencamfamin
   4. D. Fenproporex
   5. E. Mazindol
   6. F. Mefenorex
   7. G. Modafinil
   8. H. Pemoline (including organometallic complexes and chelates thereof)
   9. I. Phentermine
   10. J. Pipradrol
   11. K. Serdexmethylphenidate
   12. L. Sibutramine
   13. M. Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, betaamino-, carbamate (ester))
   14. N. SPA (-)-1-dimethylamino-1,2- diphenylethane
   15. 5. Other substances. Unless specifically excepted or unless

listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts:

1. A. Pentazocine
2. B. Butorphanol (including its optical isomers) 9720
3. C. Eluxadoline (5-[[[(2S)-2-amino-3-[4- aminocarbonyl)-2,6-dimethylphenyl]-1- oxopropyl] [(1S)-1-(4-phenyl-1 H-imidazol-2-yl) ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers
4. 6. Ephedrine. Any material, compound, mixture, or

preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system including their salts, isomers, and salts of isomers:

1. A. Ephedrine or its salts, optical isomers, or salts of

optical isomers as the only active medicinal ingredient or contains ephedrine or its salts, optical isomers, or salts of optical isomers and therapeutically insignificant quantities of another active medicinal ingredient.

1. (E) Schedule V shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this subsection.

   1. 1. Narcotic drugs containing nonnarcotic active medicinal

ingredients. Any compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as follows, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:

1. A. Not more than one hundred milligrams (100 mg) of

dihydrocodeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

1. B. Not more than one hundred milligrams (100 mg) of

ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);

1. C. Not more than two and five-tenths milligrams (2.5 mg)

of diphenoxylate and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit;

1. D. Not more than one hundred milligrams (100 mg) of

opium per one hundred milliliters (100 mL) or per one hundred grams (100 gm); and

1. E. Not more than five-tenths milligram (0.5 mg) of

difenoxin (DEA Drug Code No. 9168) and not less than twentyfive micrograms (25 mcg) of atropine sulfate per dosage unit. 1230 2. Stimulants. Unless specifically exempted or excluded 1610 or unless listed in another schedule, any material, compound, 1760 mixture, or preparation which contains any quantity of the 1575 following substances having a stimulant effect on the central 1605 nervous system including its salts, isomers, and salts of isomers:

1680 3. Any compound, mixture, or preparation containing any detectable quantity of pseudoephedrine or its salts or optical 1530 isomers, or salts of optical isomers or any compound, mixture, 1640 or preparation containing any detectable quantity of ephedrine 1750 or its salts or optical isomers, or salts of optical isomers if the 1729 drug preparations are starch-based solid dose forms, if such 1675 preparations are sold over the counter without a prescription. The following drug preparations containing ephedrine and pseudoephedrine are not scheduled controlled substances:

1635 to be dispensed.

1. 4. Unless specifically exempted or excluded or unless

listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous

9709 system, including its salts:

1. (2) Excluded Nonnarcotic Substances. The following nonnarcotic substances which, under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301) and section 201(g)(1) of the federal Controlled Substances Act (21 U.S.C. 811(g)(1)), may be lawfully sold over the counter without a prescription, are excluded from all schedules pursuant to section 195.015(5), RSMo.

1. A. Pyrovalerone 1485
2. A. Drug preparations in liquid form; and
3. B. Drug preparations that require a prescription in order
4. A. Ezogabine [N-[2-amino-4(4- fluorobenzylamino)-phenyl]- carbamic acid ethyl ester] 2779
5. B. Ganaxolone (3α-hydroxy-3β-methyl- 5α-pregnan-20-one)
6. C. Lacosamide [(R)-2-acetoamido-N-benzyl- 3-methoxy-propionamide] 2746
7. D. Pregabalin [(S)-3-(aminomethyl)-5- methylhexanoic acid] 2782
8. E. Brivaracetam ((25)-2-[(4R)- 2-oxo-4-propylpyrrolidin-1- yl]butanamide) (also referred to as BRV; UCB-34714; Briviact) 2710
9. F. Lasmiditan [2,4,6-trifluoro-N-(6-(1- methylpiperidine-4-carbonyl) pyridine-2- yl-benzamide] 2790
10. G. Cenobamate ([(1R)-1-(2- chlorophenyl)-2-(tetrazol- 2-yl)ethyl] carbamate; 2H- tetrazole-2-ethanol, alpha-(2- chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H- tetrazol-2-yl)ethyl ester) 2720 Company

Bioline Laboratories Aphena Pharma Solutions—New York, LLC Goldline Laboratories Goldline Laboratories Hawthorne Products, Inc. Parke-Davis & Co. Parke-Davis & Co. Parke-Davis & Co. Parke-Davis & Co. Parmed Pharmacy Rondex Labs Smith Kline Consumer Sterling Drug, Inc. Sterling Drug, Inc. Vicks Chemical Co. White Hall Labs

AUTHORITY: section 195.015, RSMo Supp. 2024, and section 195.195, RSMo 2016.* Material found in this rule previously filed as 19 CSR 30-1.010. Original rule filed April 14, 2000, effective Nov. 30, 2000. Amended: Filed Jan. 31, 2003, effective July 30, 2003. Amended: Filed Sept. 30, 2016, effective May 30, 2017. Emergency amendment filed Oct. 25, 2018, effective Nov. 4, 2018, expired May 2, 2019. Amended: Filed Oct. 25, 2018, effective April 30, 2019. Emergency amendment filed Oct. 30, 2020, effective Nov. 16, 2020, expired May 14, 2021. Amended: Filed Oct. 30, 2020, effective April 30, 2021. Emergency amendment filed Sept. 28, 2021, effective Oct. 13, 2021, expired April 10, 2022. Amended: Filed Sept. 28, 2021, effective March 30, 2022. Emergency amendment filed Sept. 12, 2022, effective Oct. 3, 2022, expired March 31, 2023. Amended: Filed Sept. 12, 2022, effective March 30, 2023. Emergency amendment filed Sept. 25, 2023, effective Oct. 10, 2023, expired April 6, 2024. Amended: Filed Sept. 5, 2023, effective March 30, 2024. Emergency amendment filed Sept. 24. 2024, effective Oct. 8, 2024, expired April 5, 2025. Amended: Filed Sept. 24, 2024, effective April 30, 2025. *Original authority: 195.015, RSMo 1971, amended 1989, 2014, 2020, and 195.195, RSMo 1957, amended 1971, 1989, 1993, 2014.